PDCD1 and neoplasm: Expression of PD-1 on CD8+ tumor-infiltrating lymphocytes has previously been shown to accurately identify clonally expanded tumor-reactive T cells, indicating its potential as a predictive biomarker of antitumor responses induced by ICB32, and recent findings have provided further support for the predictive value of CD8+PD-1+ TCI17,33,34.